Hello, Fool! | Login | Signup | My Fool
Jan 9, 2009 4:34 PM ET | Feedback | Site Changes | Help
The Company is engaged in the research, development and commercialization of innovative treatments for the relief of moderate to severe pain.
View All Commentary (JAV)
Recs
ethanbryson (< 20) Submitted: 5/09/08 10:35 AM : Start Price: $2.65 JAV Score: -9.02
The market for pain management drugs is enormous and continues to grow. Each of the three products (one of which is already approved and on the market in Europe) this company is bringing to market is a reformulation of an existing drug with a proven safety record. Though I believe biotech stocks are always a gamble, I see very little downside and considerable upside for this stock over the next few years.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
Terms & Conditions
RSS Headlines
Fool UK